Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma
Authors:
- Byung-Keun KimBKByung-Keun Kim
- Ga-Young BanGBGa-Young Ban
- Mi-Ae KimMKMi-Ae Kim
- Ji-Hyang LeeJLJi-Hyang Lee
- Jin AnJAJin An
- Ji-Su ShimJSJi-Su Shim
- Youngsoo LeeYLYoungsoo Lee
- Ha-Kyeong WonHa-Kyeong Won
- Hwa Young LeeHLHwa Young Lee
- Kyoung-Hee SohnKSKyoung-Hee Sohn
- Sung-Yoon KangSKSung-Yoon Kang
- So Young ParkSPSo Young Park
Open Access
- 1 January 2020
- journal article
- review article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 12 (6) , 910-933
Abstract
Kim BK, et al. Allergy Asthma Immunol Res. 2020 Nov;12(6):910-933. https://doi.org/10.4168/aair.2020.12.6.910Keywords
Funding Information
- Ministry of Health and Welfare (HC19C0318)
This publication has 77 references indexed in Scilit:
- Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly PatientsJournal of Asthma, 2012
- American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up reportJournal of Allergy and Clinical Immunology, 2011
- Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthmaAllergy, 2011
- Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)Thorax, 2010
- Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe AsthmaJournal of Allergy and Clinical Immunology, 2010
- Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmaticsAllergy, 2009
- Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEAllergy, 2004
- Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJournal of Allergy and Clinical Immunology, 2004
- Asthma control in the Asia-Pacific region: The asthma insights and reality in Asia-Pacific studyJournal of Allergy and Clinical Immunology, 2003
- Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trialThe Lancet, 2001